Medical Retina Care

The physicians at Charles Retina Institute are world-renowned specialists for medical retina care. Numerous publications demonstrate their cutting edge position in the diagnosis and management of a variety of diseases, including dry and wet age-related macular degeneration, diabetic retinopathy, circulatory problems such as vein and artery occlusions or ocular ischemic syndrome, histoplasmosis, myopic macular degeneration, central serous retinopathy, sickle cell retinopathy, ischemic optic neuropathy and optic neuritis. We also treat rare conditions such as macroaneurysms, parafoveal telangiectasia, Coats’ disease, Eales’ disease, radiation retinopathy, and familial exudative vitreoretinopathy or late complications of retinopathy of prematurity.

Furthermore, inflammatory disorders as varied as acute multifocal posterior placoid pigment epitheliopathy (AMPPPE), serpiginous choroiditis, birdshot retinochoroidopathy, sympathetic ophthalmia, Vogt-Koyanagi-Harada (VKH) Syndrome, multiple evanescent white dot syndrome (MEWDS), acute macular neuroretinopathy (AMN), acute retinal pigment epitheliitis, intermediate uveitis/pars planitis, multifocal choroiditis/punctate inner choroidopathy, posterior scleritis, and complications of sarcoidosis and rheumatic disease are routinely taken care of at Charles Retina Institute. The same is true for infections such as toxoplasmosis, ocular toxocariasis, as well as viral syndromes, HIV, and bacterial and fungal infections. Drug toxicities are a further area of specialty, as are intraocular tumors, such as choroidal nevus, congenital hypertrophy of the retinal pigment epithelium (CHRPE), posterior uveal melanoma, retinal capillary hemangioma, retinal cavernous hemangioma, retinal astrocytoma choroidal hemangioma, choroidal osteoma, metastasis, and other manifestations of systemic malignancy, such as leukemia and lymphoma.

The full complement of ocular imaging, including fluorescein and indocyanine green angiography, optical coherence tomography, wide-field imaging, confocal retinal imaging, adaptive optics, and microperimetry, is available to aid in the timely and correct diagnosis of difficult to recognize entities. Also, multi-wavelength lasers as well as the full range of injectable drugs including Lucentis, Eylea, Avastin, Triescence, Kenalog, and Dexamethasone are available in the office to provide you will all possible options for tackling challenging diseases.

Where a team approach is key, the physicians at Charles Retina Institute take advantage of their close working relationships with top specialists in other fields such as rheumatology, oncology, and laboratory medicine to manage complex manifestations of systemic disease at some of the world’s most renowned institutions.